Allows Extracorporeal Eradication of Pathogens from Cerebral Spinal Fluid Through Radio Frequency and/or Laser Emissive Power
JACKSON CENTER, PA / ACCESSWIRE / June 16, 2021 / Halberd Corporation (OTC PINK:HALB) has efficiently conjugated, Tau, Phosphorylated Tau and Beta Amyloid antibodies with gold-coated iron oxide nanoparticles in a patent-pending course of. These three antigens, that are present in Cerebral Spinal Fluid (CSF), are related to the formation of neurofibrillary tangles concomitant with Alzheimer’s Illness. Conjugation of those antibodies with gold-coated iron oxide particles offers the idea for the extracorporeal elimination and eradication of those Alzheimer’s Illness-associated peptides and proteins from Cerebral Spinal Fluid (CSF) via publicity to tuned radio frequency vitality and/or laser emissive vitality.
Dr. Shawn Q. Chen and his staff at GreenBioAz, an Arizona State College incubator firm are spearheading this analysis.
Dr. Mitchell S. Felder, Halberd’s Chief Technical Officer, and a board licensed attending Neurologist, acknowledged, “There are quite a few medical articles which point out a correlation between the formation of neurofibrillary tangles and amyloid plaques within the onset and development of Alzheimer’s Illness. Three important constituents recognized as resulting in neuropathological modifications in Alzheimer’s Illness are Phosphorylated Tau, Tau, and Beta Amyloid. We imagine that if we will eradicate adequate portions of those compounds from CSF then we will sluggish or arrest the event of neurofibrillary tangles and amyloid plaques, and due to this fact, the development of Alzheimer’s Illness.”
William A. Hartman, Halberd’s Chairman, President & CEO, commented, “Alzheimer’s Illness impacts greater than six million folks in the US and as many as 40 million folks worldwide, and these numbers are solely projected to worsen. By 2050, it’s estimated that as many as 14 million Individuals over the age of 65 might be affected by a point of Alzheimer’s. We imagine that we’re uniquely positioned to counter this pattern via our patented extracorporeal methodology of capturing the offending constituents in CSF on the mobile degree and safely and effectively destroying them via publicity to tuned radio waves or alternatively, laser vitality. Each such processes are coated by our patented and patent-pending applied sciences.”
“We’ve now secured the required antibodies and antigens for our Alzheimer’s Illness experimentation. We’re within the strategy of finishing preliminary proof-of-concept testing utilizing E.coli as a surrogate at Youngstown State College (YSU). As well as, now we have commenced planning animal assessments. Animal assessments are vital to exhibit security and efficacy of our course of. Our primary focus is to the profitable conclusion of the experimentation involving Alzheimer’s Illness antigen elimination.”
“As a staff, we’re extraordinarily excited on the prospects of creating a profitable therapy for this illness which has plagued untold numbers of individuals worldwide for hundreds of years. That is really revolutionary analysis and growth.”
For extra data please contact:
About Halberd Corporation.
Halberd Corporation (OTC-PINK:HALB), is a publicly traded firm on the OTC Market, and is in full compliance with OTC Market reporting necessities. It holds the unique worldwide rights to a number of patent- and PCT-pending extracorporeal therapies for COVID-19 and different medical maladies: Halberd additionally holds the unique rights to the underlying granted U.S. Patent 9,216,386 and U.S. Patent 8,758,287.
Secure Harbor Discover
Sure statements contained herein are “forward-looking statements” (as outlined within the Non-public Securities Litigation Reform Act of 1995). The Firms warning that statements, and assumptions made on this information launch represent forward-looking statements and makes no assure of future efficiency. Ahead-looking statements are primarily based on estimates and opinions of administration on the time statements are made. These statements might deal with points that contain important dangers, uncertainties, estimates made by administration. Precise outcomes may differ materially from present projections or implied outcomes. The Firms undertake no obligation to revise these statements following the date of this information launch.
Investor warning/added threat for buyers in firms claiming involvement in COVID-19 initiatives –
On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public assertion on the significance of disclosure in the course of the COVID-19 disaster.
The SEC and Self-Regulatory Organizations are focusing on public firms that declare to have merchandise, therapy or different methods with regard to COVID-19.
The final word affect of the COVID-19 pandemic on the Firm’s operations is unknown and will rely on future developments, that are extremely unsure and can’t be predicted with confidence, together with the length of the COVID-19 outbreak. Moreover, new data might emerge in regards to the severity of the COVID-19 pandemic, and any extra preventative and protecting actions that governments, or the Firm, might direct, which can lead to an prolonged interval of continued enterprise disruption, decreased buyer visitors and decreased operations. Any ensuing monetary affect can’t be moderately estimated presently.
We additional warning buyers that our main focus and objective is to battle this pandemic for the nice of the world. As such, it’s attainable that we might discover it essential to make disclosures that are in keeping with that objective, however which can be adversarial to the pecuniary pursuits of the Firm and of its shareholders.
SOURCE: Halberd Corporation